Skip to main content

Table 1 U251 secretome after treatment with pre-miR-93 or antagomiR-93

From: Regulation of IL-8 gene expression in gliomas by microRNA miR-93

Protein Release (pg/ml) Fold release after pre-miR-93 treatment Fold release after antagomiR-93 treatment miR-93 dependency (miR-93INDEX)a
PDGF-bb 5.96 0.40 1.76 0.23
IL-1ra 475.02 0.49 0.80 0.61
IL-2 3.84 1.32 0.62 2.10
IL-6 85.8 0.39 1.28 0.30
IL-7 4.17 0.38 1.64 0.23
IL-8 838.38 0.27 1.63 0.17
IL-9 3.53 0.59 1.47 0.40
IL-10 25.15 0.48 1.57 0.30
IL-12 105.99 0.46 1.59 0.29
IL-15 9.60 0.72 0.40 1.80
IL-17 14.80 0.50 1.09 0.47
FGF 49.55 0.52 1.33 0.39
G-CSF 6.30 0.53 1.37 0.39
GM-CSF 114.50 0.49 1.44 0.34
IFN-γ 14.47 0.36 1.32 0.27
IP-10 7.80 0.45 1.37 0.33
MCP-1(MCAF) 4743.32 0.38 1.51 0.25
MIP-1β 2.35 0.59 1.27 0.47
RANTES 13.69 0.68 1.32 0.51
TNF-α 8.51 0.43 1.32 0.33
VEGF 9469.12 0.49 1.56 0.31
  1. amiR-93 dependency: fold (pre-miR-93 treatment)/fold (antagomiR-93 treatment)